University of Oxford Vaccinates First Participant in World-First Trial
6 Articles
6 Articles
University of Oxford vaccinates first participant in world-first trial
Researchers from the Oxford Vaccine Group administered the dose in the first clinical trial of a vaccine targeting the Bundibugyo ebolavirus.
The first volunteer on Friday received a dose of a new experimental vaccine against the Bundibugyo strain that is causing a deadly Ebola outbreak in the Democratic Republic of Congo. The Ebola outbreak has already claimed more than a thousand lives in the Democratic Republic of Congo and Uganda.
The clinical trial conducted by the University of Oxford takes place at a time when the epidemic has already killed 1,300 people in the Democratic Republic of the Congo.
A first volunteer was vaccinated with a specific experimental vaccine against Bundibugyo strains of the Ebola virus, which killed over 1,000 people in the Democratic Republic of Congo (DRC) and Uganda, Oxford University reports.
Coverage Details
Bias Distribution
- 67% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium




